# Validation of MMS Test for Cancer Monitoring

> **NCT02113683** · — · TERMINATED · sponsor: **MedInnovation GmbH** · enrollment: 100 (actual)

## Conditions studied

- Colo-rectal Cancer
- Stomach Cancer
- Melanoma
- Sarcoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02113683
- **Lead sponsor:** MedInnovation GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-20
- **Target enrollment:** 100 (ACTUAL)
- **Why stopped:** insufficient recruitment on the part of clinic; study will not resume
- **Last updated:** 2018-06-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02113683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02113683, "Validation of MMS Test for Cancer Monitoring". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02113683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*